| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000048490 |
| Receipt No. | R000055258 |
| Scientific Title | Risk factors for stent failure after drug-eluting stent implantation for calcified nodule: An optical coherence tomography study |
| Date of disclosure of the study information | 2022/08/01 |
| Last modified on | 2022/07/27 (Ver. 1) |
| Basic information | ||
| Public title | Risk factors for stent failure after drug-eluting stent implantation for calcified nodule: An optical coherence tomography study
|
|
| Acronym | Risk factors for stent failure after drug-eluting stent implantation for calcified nodule: An optical coherence tomography study | |
| Scientific Title | Risk factors for stent failure after drug-eluting stent implantation for calcified nodule: An optical coherence tomography study | |
| Scientific Title:Acronym | Risk factors for stent failure after drug-eluting stent implantation for calcified nodule: An optical coherence tomography study | |
| Region |
|
|
| Condition | ||
| Condition | coronary artery disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate the risk factor for stent failure after drug-eluting stent implantation for calcified nodule. |
| Basic objectives2 | Others |
| Basic objectives -Others | investigation of risk factor |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Target lesion revascularization |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) patients who underwent OCT-guided PCI from August 2013 to October 2020
(2)patients whose culprit lesion had CN detected by pre PCI OCT |
|||
| Key exclusion criteria | (1)patients who were not implanted drug-eluting stents (DES) (those treated with drug-coated balloon [DCB], and those treated with percutaneous old balloon angioplasty [POBA] or rotation atherectomy [RA] alone)
(2)those with in-stent restenosis (3)those with coronary artery bypass grafted lesions (4)those with insufficient OCT data quality (5)those who died within a year after the index PCI |
|||
| Target sample size | 120 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kobe University Graduate School of Medicine | ||||||
| Division name | Division of Cardiovascular Medicine | ||||||
| Zip code | 6500017 | ||||||
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe | ||||||
| TEL | 0783825846 | ||||||
| hotake@med.kobe-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kobe University Graduate School of Medicine | ||||||
| Division name | Division of Cardiovascular Medicine | ||||||
| Zip code | 6500017 | ||||||
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe | ||||||
| TEL | 0783825846 | ||||||
| Homepage URL | |||||||
| tomohamachi@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Kobe University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kobe University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kobe university hospital clinical and translational research center |
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe |
| Tel | 0783826669 |
| ccrspprt@med.kobe-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 120 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Multicenter, retrospective, observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055258 |